ArticleFrontiers in pharmacology2022

Conventional Synthetic Disease-Modifying Anti-rheumatic Drugs for Psoriatic Arthritis: Findings and Implications From a Patient Centered Longitudinal Study in Brazil.

Ronaldo José Faria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.